Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 362 of 1,261
  1. US 10934534

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  2. US 10934527

    Generation of lineage-restricted progenitor cells from differentiated cells

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  3. US 10934545

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  4. US 10935554

    Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (SIT)

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  5. US 10934337

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  6. US 10934305

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  7. US 10934334

    Peptides for angiogenic therapy

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  8. US 10934332

    Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  9. US 10934264

    Amyloid targeting agents and methods of using the same

    The Regents of the University of California · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  10. US 10934274

    Quinoline derivatives as TAM RTK inhibitors

    Lead Discovery Center GmbH · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  11. US 10933136

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  12. US 10934260

    Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

    MEREO BIOPHARMA 1 LIMITED · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  13. US 10933137

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  14. US 10934299

    Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  15. US 10933126

    Clostridium difficile immunogenic compositions and methods of use

    The Board of Regents of the University of Oklahoma · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  16. US 10934270

    Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  17. US 10933086

    Composition for preventing, alleviating, or treating arthritis or osteoporosis, containing neoagarooligosaccharide

    DYNEBIO INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  18. US 10933078

    Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

    The Board of Regents of the University of Texas System · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  19. US 10933076

    Crocin-sorafenib combination therapy for liver cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  20. US 10933071

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  21. US 10933066

    Methods and compositions for treatment of Zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  22. US 10933042

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  23. US 10933056

    3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor

    MSD R&D (China) Co. Ltd. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  24. US 10932484

    Inhibitory activity of acetogenins against Listeria monocytogenes

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.